Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen MacKay

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
JAMA Oncology|November 18, 2017
Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus-Related Cervical CarcinomaStephanie Lheureux, Marcus O Butler, Blaise Clarke, et al.
Nature Communications|July 23, 2021
Vulnerability of the North Water ecosystem to climate changeSofia Ribeiro, Audrey Limoges, Guillaume Massé, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian CancerKim Ma, Basile Tessier-Cloutier, Alon D Altman, et al.
Gynecologic Oncology|March 18, 2025
Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trialCharles A Leath, Wei Deng, Loren K Mell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 21, 2026
Lenvatinib plus pembrolizumab in participants with advanced or recurrent endometrial cancer: Study 309/KEYNOTE-775 and ENGOT-en9/LEAP-001 post-(neo)adjuvant therapy outcomesChristian Marth, Domenica Lorusso, Mariusz Bidziński, et al.
Nature Medicine|July 1, 2024
Author Correction: Prediction of recurrence risk in endometrial cancer with multimodal deep learningSarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, et al.
Nature Medicine|May 24, 2024
Prediction of recurrence risk in endometrial cancer with multimodal deep learningSarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2021
Clinical Cancer Advances 2021: ASCO's Report on Progress Against CancerSonali M Smith, Kerri Wachter, Howard A Burris, et al.
The Lancet. Oncology|July 13, 2013
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyWeiva Sieh, Martin Köbel, Teri A Longacre, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
JAMA Oncology|November 18, 2017
Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus-Related Cervical CarcinomaStephanie Lheureux, Marcus O Butler, Blaise Clarke, et al.
Nature Communications|July 23, 2021
Vulnerability of the North Water ecosystem to climate changeSofia Ribeiro, Audrey Limoges, Guillaume Massé, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian CancerKim Ma, Basile Tessier-Cloutier, Alon D Altman, et al.
Gynecologic Oncology|March 18, 2025
Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trialCharles A Leath, Wei Deng, Loren K Mell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 21, 2026
Lenvatinib plus pembrolizumab in participants with advanced or recurrent endometrial cancer: Study 309/KEYNOTE-775 and ENGOT-en9/LEAP-001 post-(neo)adjuvant therapy outcomesChristian Marth, Domenica Lorusso, Mariusz Bidziński, et al.
Nature Medicine|July 1, 2024
Author Correction: Prediction of recurrence risk in endometrial cancer with multimodal deep learningSarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, et al.
Nature Medicine|May 24, 2024
Prediction of recurrence risk in endometrial cancer with multimodal deep learningSarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2021
Clinical Cancer Advances 2021: ASCO's Report on Progress Against CancerSonali M Smith, Kerri Wachter, Howard A Burris, et al.
The Lancet. Oncology|July 13, 2013
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyWeiva Sieh, Martin Köbel, Teri A Longacre, et al.
Pageof 7